NCT03414892View on ClinicalTrials.gov

Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

January 4, 2019

Study Completion Date

December 1, 2019

Conditions
Hyperglycaemia (Diabetic)Type 2 Diabetes Mellitus
Interventions
DRUG

Globalagliatin Hydrochloride

once daily, oral

DRUG

Placebo

once daily, oral

Trial Locations (1)

Unknown

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Yabao Pharmaceutical Group

INDUSTRY

NCT03414892 - Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter